Purple Biotech Ltd ADR (PPBT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Operating Expenses | 27,458 | 11,005 | 22,271 | 22,603 | 17,934 |
| Operating Income | -27,458 | -11,005 | -22,271 | -22,603 | -17,934 |
| Interest Expense | 982 | 483 | 2,195 | 67 | 212 |
| Other Income | 1,948 | 4,209 | 4,489 | 910 | 320 |
| Pre-tax Income | -26,492 | -7,279 | -19,977 | -21,760 | -17,826 |
| Net Income Continuous | -26,492 | -7,279 | -19,977 | -21,760 | -17,826 |
| Net Income Discontinuous | N/A | N/A | N/A | N/A | -642 |
| Minority Interests | -106 | -39 | -97 | -92 | -84 |
| Net Income | $-26,386 | $-7,240 | $-19,880 | $-21,668 | $-18,384 |
| EPS Basic Total Ops | -54.96 | -44.40 | -179.60 | -240.00 | -202.00 |
| EPS Basic Continuous Ops | -55.19 | -44.40 | -180.46 | -240.69 | -202.94 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | N/A | -7.31 |
| EPS Diluted Total Ops | -54.96 | -44.40 | -179.60 | -240.00 | -202.00 |
| EPS Diluted Continuous Ops | -55.19 | -44.40 | -180.46 | -240.69 | -202.94 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | N/A | -7.31 |
| EPS Diluted Before Non-Recurring Items | -54.96 | -49.90 | -218.00 | -216.00 | -202.00 |
| EBITDA(a) | $-27,255 | $-10,819 | $-22,074 | $-22,402 | $-17,703 |